scholarly journals Glycosylated Hemoglobin A1c Improves the Performance of the Nomogram for Predicting the 5-Year Incidence of Type 2 Diabetes

2020 ◽  
Vol Volume 13 ◽  
pp. 1753-1762
Author(s):  
Chun-Ming Ma ◽  
Fu-Zai Yin
Keyword(s):  
Type 2 Diabetes ◽  
Hemoglobin A1c ◽  
Glycosylated Hemoglobin ◽  
Glycosylated Hemoglobin A1c

scholarly journals The Eradication of Helicobacter pylori does not Affect Glycemic Control in Japanese Subjects with Type 2 Diabetes

2013 ◽  
Vol 4 ◽  
pp. JCM.S10828 ◽  
Author(s):  
Yoshiharu Wada ◽  
Yoshiyuki Hamamoto ◽  
Yukiko Kawasaki ◽  
Sachiko Honjo ◽  
Kanta Fujimoto ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Helicobacter Pylori ◽  
Glycemic Control ◽  
Hemoglobin A1c ◽  
Glycosylated Hemoglobin ◽  
Eradication Therapy ◽  
Glycosylated Hemoglobin A1c ◽  
H Pylori ◽  
Japanese Subjects

Since infection with Helicobacter pylori has been suggested to play a pathogenic role in diabetes mellitus, we investigated whether eradication therapy for H. pylori might affect glycemic control in Japanese subjects with type 2 diabetes. A total of 72 subjects (55 males, 17 females; aged 63.7 years) with type 2 diabetes who received eradication therapy for H. pylori were included. The change of their blood glycosylated hemoglobin (A1C) levels 3 months before (-3 m) the H. pylori eradication, as well as 3 months (3 m) and 6 months (6 m) after were evaluated. Their A1C levels did not show any significant change after therapy {6.9 [0.1]% (-3 m) to 7.0 [0.1]% (3 m); P = 0.3, 7.0 [0.1] (6 m); P = 0.3}. Our findings suggest that the eradication therapy for H. pylori does not, at least profoundly, affect glycemic control in Japanese subjects with type 2 diabetes.

Relation Between Glycosylated Hemoglobin (Hemoglobin A1c) and Aortic Stiffness in Patients with Type 2 Diabetes

2017 ◽  
Vol 20 (2) ◽  
pp. 137-142
Author(s):  
Taner Şen ◽  
Erkan Kahraman ◽  
Saadet Güven ◽  
Serkan Topaloğlu ◽  
Şule Korkmaz
Keyword(s):  
Type 2 Diabetes ◽  
Aortic Stiffness ◽  
Hemoglobin A1c ◽  
Glycosylated Hemoglobin

Standardized Follow-Ups Lower HbA1c in Adults With Type 2 Diabetes Living in a Rural Community: A Pilot Study

2018 ◽  
Vol 11 (1) ◽  
pp. 16-24 ◽  
Author(s):  
Katherine Jean Coulter
Keyword(s):  
Type 2 Diabetes ◽  
Rural Health ◽  
Effect Size ◽  
Statistical Significance ◽  
Glycosylated Hemoglobin ◽  
Office Visits ◽  
Glycosylated Hemoglobin A1c ◽  
Hba1c Levels

Aim:To implement and evaluate the use of a standardized process, which includes the teach-back method for follow-up among patients with type 2 diabetes in rural health care settings in order to reduce glycosylated hemoglobin A1c (HbA1c) in adults with diabetes.Background:It remains unclear whether or not controlled patient follow-up among patients with type 2 diabetes between office visits (at 3-month intervals) is effective in reducing their HbA1c.Method:This study recruited 12 participants from a rural health family practice in Northern Illinois to participate in a pretest–posttest study to evaluate if close patient follow-up with reinforced education was effective in helping patients reduce their HbA1c.Results:The preintervention for HbA1c and postintervention HbA1c mean difference was found to be statistically significant. The HbA1c level decreased from preintervention to postintervention (p < .05). Further, the mean and standard deviation from the preintervention for HbA1c and postintervention HbA1c were used to calculate an effect size using Cohen’s d found that there was a medium to large effect size d = .67. The change in HbA1c levels was of clinical significance as well as statistical significance.Conclusion:The use of a standardized process for patient follow-up as part of routine management of type 2 diabetes appears to have had a clinically as well as statistically significant impact in reducing HbA1c levels.

Sign in / Sign up

Export Citation Format

Share Document